Tikcro Technologies Ltd.
TIKRF
Tikcro Technologies Ltd., an Israeli enterprise, is primarily involved in... Tikcro Technologies Ltd., an Israeli enterprise, is primarily involved in advancing biotechnology projects. Among its offerings is anti-cytotoxic T-lymphocyte-associated protein 4, which is utilized for immunotherapeutic approaches to cancer. The company, established in 1999, was previously known as Tioga Technologies Ltd. before rebranding to its current name in September 2003. Its main office is located in Hadera, Israel.
